Cancer Research UK logo.
SearchDonate
  • Search

A study of CHOP and Campath for peripheral T cell lymphoma (CHOP-CAMPATH)

Overview

Cancer types:

Low grade lymphoma, Non-Hodgkin lymphoma (NHL)

Status:

Closed

Phase:

Phase 1

Details

This pilot study is looking at chemotherapy with different doses of Campath as the first treatment for peripheral T cell lymphoma. This trial is supported by Cancer Research UK.

Recruitment start: 15 May 2007

Recruitment end: 31 December 2011

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Rod Johnson

Supported by

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Schering Healthcare Ltd

University College London (UCL)

Other information

This is Cancer Research UK trial number CRUKE/04/016.

Last reviewed: 11 December 2013

CRUK internal database number: 546

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.